Barclays Starts NovoCure Ltd. (NVCR) at Underweight
Tweet
Share
E-mailGet Alerts NVCR Hot Sheet
Price: $12.25 -0.73%
Rating Summary:
9 Buy, 6 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 9
Rating Summary:
9 Buy, 6 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 9
Join SI Premium – FREE
Barclays initiated coverage on NovoCure Ltd. (NASDAQ: NVCR) with an Underweight rating and a price target of $16.00.
For an analyst ratings summary and ratings history on NovoCure Ltd. click here. For more ratings news on NovoCure Ltd. click here.
Shares of NovoCure Ltd. closed at $17.79 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Berenberg Starts Lloyds TSB Group (LYG) at Hold, 'shares are fairly valued'
- JPMorgan Starts Universal Store Holdings (UNI:AU) at Overweight
- H.C. Wainwright Starts Processa Pharmaceuticals (PCSA) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
